Prostate specific deletion of Rictor was found to supress PTEN driven tumourigenesis downstream of Akt in mice and mTORC2 mediates Akt dependent chemotherapy resistance in PTEN null glioma patients [15], indicating the importance of mTORC2 as a PI3kinase effector pathway. This evidence concerns the gene AKT1 and glioma.